Aspire Biopharma authorizes $5 million share repurchase program

April 27, 2026 8:37 AM

Aspire Biopharma Holdings Inc. (NASDAQ: ASBP) announced that its board of directors has authorized the repurchase of up to $5 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found